# US 2026/0233224 A1 · Nucleic acid extraction and purification cartridges

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0233224 A1
- Document ID: US20260233224A1
- Status: Published application
- Kind: A1
- Application number: 19/336,646
- Filed: 2025-09-23
- Published: 2026-08-13
- Earliest claimed: 2017-06-15
- Assignees: Manta Biosystems, Inc.
- Applicants: Manta Biosystems, Inc.
- Inventors: John Regan; John DePiano
- Web page: https://patentgrep.com/patent/US20260233224A1

## CPC

- B01L 3/502: {with fluid transport, e.g. in multi-compartment structures}
- B01L 3/502746: {characterised by the means for controlling flow resistance, e.g. flow controllers, baffles or throttle valves}
- B01L 3/567: {Valves, taps or stop-cocks}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G01N 1/10: in the liquid or fluent state {(burettes, pipettes B01L3/02; sampling of ground water E02D1/06; metering by volume of fluids or fluent solid material G01F11/00, G01F13/00)}
- G01N 1/405: {by adsorption or absorption}
- G01N 35/1009: {Characterised by arrangements for controlling the aspiration or dispense of liquids}
- G01N 35/1095: {for supplying the samples to flow-through analysers (for a specific analyser see relevant groups, e.g. under G01N15/00, G01N21/00, G01N27/00, G01N30/00, H01J49/00)}
- B01J 2220/62: In a cartridge
- B01L 9/50: {Clamping means, e.g. tongs}
- B01L 2200/0631: Purification arrangements, e.g. solid phase extraction [SPE]
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2300/0663: Whole sensors
- B01L 2300/0681: Filter
- B01L 2300/123: Flexible; Elastomeric
- B01L 2400/0433: vibrational forces
- B01L 2400/0644: rotary valves
- B01L 2400/082: Active control of flow resistance, e.g. flow controllers
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

Nucleic acid extraction and purification cartridges and systems are provided. The cartridges can be removable and are configured to allow for the concentration of particles of interest, followed by nucleic acid extraction and purification. The cartridges directly contact samples and provide a partial barrier between samples and the reusable components of the system, thereby reducing the probability of clogging the system's microfluidics and fouling the lines, valves, and pumps of the system. Furthermore, these cartridges are designed to purity nucleic acids by removing the majority of inhibitors for down-stream genetic testing. Embodiments may comprise one, two, or three or more channels, In an exemplary embodiment the nucleic acid extraction and purification cartridge comprises a first channel containing a filter disposed therein; and a second channel containing a nucleic acid binding matrix disposed therein, wherein a first end of the cartridge is configured to directly contact a sample comprising a biological material, and wherein a second end of the cartridge Is configured to connect in a reversible fashion to a flow-through automated Instrument that controls fluid flow through the cartridge.

## Claims

### Claim at position 1

1-46. (canceled)

### Claim 47

A nucleic acid extraction and purification cartridge comprising:
an inlet configured to receive a sample;
a chamber in fluidic connectivity with the inlet;
a filter extending across the chamber and separating the chamber into a first portion on a first side of the filter and a second portion on a second side of the filter;
a nucleic acid binding matrix; and
a channel configured to guide fluid from the chamber toward the nucleic acid binding matrix.

### Claim 48 (depends on 47)

The cartridge of claim 47, further comprising:
a first layer; and
a second layer joined to the first layer.

### Claim 49 (depends on 48)

The cartridge of claim 48, wherein the chamber is defined between the first layer and the second layer.

### Claim 50 (depends on 49)

The cartridge of claim 49, wherein the filter is positioned between the first layer and the second layer.

### Claim 51 (depends on 48)

The cartridge of claim 48, wherein the channel is defined between the first layer and the second layer.

### Claim 52 (depends on 47)

The cartridge of claim 47, wherein the channel is curved.

### Claim 53 (depends on 47)

The cartridge of claim 47, further comprising a backing, wherein the filter is positioned on the backing.

### Claim 54 (depends on 47)

The cartridge of claim 47, further comprising a lyophilized reagent within the cartridge.

### Claim 55 (depends on 54)

The cartridge of claim 54, wherein the lyophilized reagent comprises a lyophilized ball.

### Claim 56 (depends on 47)

The cartridge of claim 47, further comprising physical features configured to assist in lysis.

### Claim 57 (depends on 56)

The cartridge of claim 56, wherein the physical features comprise magnetic particles, non-magnetic particles, or beads.

### Claim 58 (depends on 47)

The cartridge of claim 47, wherein the channel is formed from different layers of substrate that are attached to each other.

### Claim 59 (depends on 58)

The cartridge of claim 58, wherein the layers are bonded together.

### Claim 60 (depends on 47)

The cartridge of claim 47, further comprising a planar substrate, and wherein the channel is formed in the planar substrate.

### Claim 61 (depends on 47)

The cartridge of claim 47, wherein the cartridge has a planar shape.

### Claim 62 (depends on 47)

The cartridge of claim 47, wherein the cartridge has a rectangular shape.

### Claim 63 (depends on 47)

The cartridge of claim 47, wherein the nucleic acid binding matrix comprises silica, borosilicate glass, sol-gel, a silanol-functionalized surface, or an anion-exchange resin.

### Claim 64 (depends on 47)

The nucleic acid extraction and purification cartridge of claim 47, wherein the nucleic acid binding matrix comprises a nucleic acid binding probe or aptamer.

### Claim 65

A method of extracting and purifying nucleic acids from a sample using a cartridge, comprising:
providing a cartridge comprising an inlet and a nucleic acid binding matrix;
receiving a sample into the cartridge through the inlet of the cartridge;
lysing the sample in the cartridge, resulting in lysate;
moving the lysate to the nucleic acid binding matrix to bind nucleic acids of the lysate to the nucleic acid binding matrix; and
eluting the nucleic acids off the nucleic acid binding matrix.

### Claim 66 (depends on 65)

The method of claim 65, wherein the step of lysing the sample comprises disrupting the sample with physical features.
